Loading ...
Loading ...
Loading ...
Table 6. Cross-reactivity summary for QIAreach™ Anti-SARS-CoV-2 Total test*
Pathogen Sample type N
Number of
cross-
reactive
Number of
non-
reactive
Adenovirus Plasma 28 0 28
Anti-nuclear Antibody (ANA) Serum 5 0 5
Bordetella pertussis Plasma 31 0 31
Chlamydia pneumoniae Plasma 42 0 42
CoV 229E Serum 17 0 17
CoV HKU1 Serum 5 0 5
CoV NL63 Serum 5 0 5
CoV OC43 Serum 14 0 14
Dengue Serum 10 0 10
Enterovirus Plasma 20 0 20
Haemophilus influenzae Plasma 5 0 5
Hepatitis B- HBc Serum 5 0 5
Hepatitis B- HBs Serum 5 0 5
Hepatitis C Serum 5 0 5
Influenza A Plasma 63 0 63
Influenza A Serum 5 0 5
Influenza B Plasma 72 0 72
Legionella pneumophila Plasma 12 0 12
Mycoplasma pneumoniae Plasma 81 0 81
Parainfluenza Plasma 103 0 103
Respiratory Syncytial Virus (RSV) Plasma 76 0 76
Respiratory Syncytial Virus (RSV) Serum 5 0 5
* This table evaluatescross-reactivity separately for each pathogen category. With several specimens, containing
antibodies to multiple pathogens, somespecimens are listed more than once,but in separate pathogen categories.
QIAreach™ Anti-SA RS -CoV2 Total Test Instructions for Use 02/2021
33
Loading ...
Loading ...
Loading ...